Log in


2018 Legislative Update Part 2

15 Jun 2018 1:40 PM | Anonymous member (Administrator)

Submitted by Thomas Buckley, RPh, MPH; CSHP Legislative Chair

The Connecticut General Assembly ended their 2018 session on May 8th with a number of bills that included pharmacists and/or pharmacy practice. While there were at least 50 bills that we were actively monitoring that did not pass, the following bills did pass which may affect pharmacy practice, although in some cases not affecting hospital inpatient practice.

AN ACT CONCERNING PRESCRIPTION DRUG COSTS: HB 5384

This bill will impose additional disclosure and reporting requirements on pharmacy benefits managers, health carriers, pharmaceutical manufacturers, the Office of Health Strategy and the Insurance Department concerning prescription drug rebates and the cost of prescription drugs.

PHARMACY AND DRUG CONTROL STATUTES: SB 195

This bill will require pharmacists to maintain perpetual inventories of Schedule II controlled substances.

AN ACT CONCERNING BIOLOGICAL PRODUCTS: SB 197

This bill will add biological products to existing law regarding substitution of generic drugs. The pharmacist may dispense an interchangeable biological product, which is therapeutically equivalent – must notify patient and prescriber within 48 hours of change (exempts hospital inpatients)

AN ACT CONCERNING PHARMACIST AND PRACTITIONER COMPLIANCE RATES AND THE ELECTRONIC PRESCRIPTION DRUG MONITORING PROGRAM: HB 5241

This bill requires the Commissioner of Consumer Protection to review pharmacists’ compliance with PMP requirements.

AN ACT LIMITING AUTO REFILLS OF PRESCRIPTION DRUGS COVERED UNDER THE MEDICAID PROGRAM: SB 246

This bill is intended to prevent unnecessary costs and clinical outcomes associated with prescriptions that are unnecessarily automatically refilled.

AN ACT CONCERNING TELEHEALTH SERVICES: SB 302

This bill adds pharmacists as providers who can administer telehealth services and modifies and clarifies patient consent procedures.

In addition to state legislative activity, ASHP has released their analysis of the Administration’s “Drug Pricing Blueprint” which was announced on May 11thAn ASHP issue briefdescribes the Administration’s drug pricing policy proposals, includes their stance on the proposals (including what is promising and what is concerning), and their next steps in working with the Administration in addressing drug costs. HHS has released a site soliciting ideas for reducing drug costs: (https://www.gpo.gov/fdsys/pkg/FR-2018-05-16/pdf/2018-10435.pdf) ASHP will be submitting comments reinforcing the necessity of engaging pharmacists in these efforts.


About CSHP

Since 1948, the Connecticut Society of Health-System Pharmacists has represented the professional interests and provided professional development for CT pharmacists, educators and pharmacists in training.

Contacts

c/o The Association Advantage, LLC

591 North Avenue

Suite 3-2

Wakefield, MA 01880-1617

Phone - Toll-free: (888) 506-3784 (506-DRUG)


Copyright © You can place your copyright information here.
Powered by Wild Apricot Membership Software